- Home
- COEP vs PCLA Comparison
COEP vs PCLA Comparison
Compare COEP & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- PCLA
- Stock Information
- Founded
- COEP 2017
- PCLA 2008
- Country
- COEP United States
- PCLA Japan
- Employees
- COEP N/A
- PCLA N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- PCLA Building Products
- Sector
- COEP Health Care
- PCLA Consumer Discretionary
- Exchange
- COEP Nasdaq
- PCLA Nasdaq
- Market Cap
- COEP 27.4M
- PCLA 32.3M
- IPO Year
- COEP N/A
- PCLA 2025
- Fundamental
- Price
- COEP $9.50
- PCLA $2.99
- Analyst Decision
- COEP
- PCLA
- Analyst Count
- COEP 0
- PCLA 0
- Target Price
- COEP N/A
- PCLA N/A
- AVG Volume (30 Days)
- COEP 38.8K
- PCLA 2.4M
- Earning Date
- COEP 08-15-2025
- PCLA 01-01-0001
- Dividend Yield
- COEP N/A
- PCLA N/A
- EPS Growth
- COEP N/A
- PCLA N/A
- EPS
- COEP N/A
- PCLA N/A
- Revenue
- COEP $62,874.00
- PCLA $5,475,228.00
- Revenue This Year
- COEP N/A
- PCLA N/A
- Revenue Next Year
- COEP N/A
- PCLA N/A
- P/E Ratio
- COEP N/A
- PCLA N/A
- Revenue Growth
- COEP N/A
- PCLA 40.19
- 52 Week Low
- COEP $2.31
- PCLA $0.37
- 52 Week High
- COEP $13.70
- PCLA $9.80
- Technical
- Relative Strength Index (RSI)
- COEP 62.66
- PCLA N/A
- Support Level
- COEP $7.25
- PCLA N/A
- Resistance Level
- COEP $9.90
- PCLA N/A
- Average True Range (ATR)
- COEP 0.68
- PCLA 0.00
- MACD
- COEP 0.22
- PCLA 0.00
- Stochastic Oscillator
- COEP 87.10
- PCLA 0.00
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.